NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Dyax Corp


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


 Refine Search
Display Mode: Context | Summary
Athera Receives Allowance of Two Key Patents
2009 NOV 1 ... pharmaceutical product candidate, PC-mAb, is developed by Athera in collaboration with Dyax Corp. in Boston, USA (NASDAQ:DYAX). The biomarker product CVDefine®, that has the ...
Subject: Cardiovascular Disease
Price: $3.00
*
DX-88 ecallantide Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
2009 NOV 23 ... trials, EDEMA3® and EDEMA4®, of DX-88, the lead product candidate of Dyax Corp. (NASDAQ:DYAX), for the treatment of acute attacks of HAE. In the time to ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Announces $15 Million Financing
2009 JUL 6 ... Dyax Corp. (NASDAQ: DYAX) announced that it has agreed to sell 7,425,743 shares of its common ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Announces Completion of Common Stock Offering
2009 OCT 19 ... Dyax Corp. (NASDAQ: DYAX) announced the completion of the public offering of 5,500,000 shares of ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Announces Developments in Licensing and Funded Research Program
2009 SEP 7 ... Dyax Corp. (NASDAQ:DYAX) announced successful advancement into Phase 1 clinical trials of two ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Announces FDA Accepts for Review the Complete Response Submission for DX-88 in Hereditary Angioedema
2009 JUN 22 ... Dyax Corp. (NASDAQ:DYAX) announced that the U.S. Food and Drug Administration (FDA) has accepted ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Announces New Developments Related to Phage Display-Discovered Drug Candidates
2009 NOV 1 ... Dyax Corp. (NASDAQ: DYAX) announced new developments involving drug candidates identified using ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Announces Pricing of Public Offering of Common Stock
2009 OCT 12 ... Dyax Corp. (NASDAQ: DYAX) announced the pricing of a public offering of 5,500,000 shares of its ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Corp. Announces First Quarter 2009 Financial Results
2009 MAY 11 ... Dyax Corp. (NASDAQ: DYAX) announced financial results for the first quarter ended March 31, 2009. ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Corp. Announces Second Quarter 2009 Financial Results
2009 AUG 3 ... Dyax Corp. (NASDAQ: DYAX) announced financial results for the second quarter ended June 30, 2009. ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Corp. Announces Third Quarter 2009 Financial Results
2009 NOV 9 ... Dyax Corp. (NASDAQ: DYAX) announced financial results for the third quarter ended September 30, ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Corp. to Host First Quarter 2009 Earnings Call and Webcast
2009 MAY 4 ... Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Corp. to Present at the Needham Life Sciences Conference
2009 JUN 22 ... Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced ...
Subject: Dyax Corp.
Price: $3.00
*
Dyax Presents Integrated Analysis of Phase 3 Data for DX-88 for Hereditary Angioedema
2009 JUN 22 ... Dyax Corp. (Nasdaq:DYAX) announced presentation of an integrated analysis of the two DX-88 Phase 3 ...
Subject: Dyax Corp.
Price: $3.00
*
James W. Fordyce Named to Ore Pharmaceuticals Board of Directors
2009 AUG 18 ... investment management firm. He is currently a member of the Board of Directors of Dyax Corp. and several privately held companies. He is Chairman Emeritus of the Board of Directors ...
Subject: Ore Pharmaceuticals Inc.
Price: $3.00
*
Reliability and Validity of Dyax's Novel Patient Reported Outcome Measures PROs Affirmed in Published Study
2009 SEP 21 ... Dyax Corp. (NASDAQ:DYAX) announced a study published evaluating the Company's novel Patient ...
Subject: Dyax Corp.
Price: $3.00
*
Reports on protease findings from D.J. Sexton and co-researchers provide new insights
2009 NOV 1 ... 2009;422(Part 2):383-392). For additional information, contact D.J. Sexton, Dyax Corp., Discovery Research, 300 Technology Sq, Cambridge, MA, USA. Publisher ...
Subject: Protease
Price: $3.00
*

Results 1 - 20      Next >

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login